Literature DB >> 10925123

Nifedipine controlled delivery by sandwiched osmotic tablet system.

L Liu1, J Ku, G Khang, B Lee, J M Rhee, H B Lee.   

Abstract

The sandwiched osmotic tablet system (SOTS), which is composed of a sandwiched osmotic tablet core surrounded by a cellulose acetate membrane with two orifices on both side surfaces, has been successfully prepared with the purpose of delivering nifedipine. The sandwiched osmotic tablet core consists of a middle push layer and two attached drug layers. Influences of tablet formulation variables, orifice size and membrane variables on nifedipine release of SOTS have been studied. It was found that potassium chloride amount of push layer and polyethylene oxide amount of drug layer had markedly positive effects on nifedipine release. A push layer/drug layer co-controlled osmotic delivery mechanism and the optimal core formulation have been proposed. The appropriate orifice size was observed in the range of 0.50-1.41 mm. It was also found that the drug release rate of SOTS could be increased by incorporating hydrophilic plasticizer in the membrane, whereas it decreased with hydrophobic plasticizer. It has been observed that the SOTS gives fairly comparable in vitro release features as that of commercialized push-pull osmotic tablet system, such as an approximately constant rate up to 24 h and independence of release media and agitation rate. Exempting side identification before drilling, it is easier to prepare the SOTS than the push-pull osmotic tablet system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925123     DOI: 10.1016/s0168-3659(00)00243-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.

Authors:  Wichan Ketjinda; Nuttanan Sinchaipanid; Pichet Limsuwan; Hans Leuenberger; Ampol Mitrevej
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

3.  Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth via three-dimensional structure mechanism.

Authors:  Abi Maharjan; Hongyu Sun; Zeying Cao; Ke Li; Jinping Liu; Jun Liu; Tiqiao Xiao; Guanyun Peng; Junqiu Ji; Peter York; Balmukunda Regmi; Xianzhen Yin; Jiwen Zhang; Li Wu
Journal:  Acta Pharm Sin B       Date:  2021-11-13       Impact factor: 14.903

4.  Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.

Authors:  Kumar Guarve; Ghanshyam Das Gupta
Journal:  Pharmaceutics       Date:  2010-05-18       Impact factor: 6.321

5.  Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores.

Authors:  Basant A Habib; Randa T Abd El Rehim; Samia A Nour
Journal:  J Adv Res       Date:  2013-06-11       Impact factor: 10.479

6.  Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation.

Authors:  Yuenan Li; Hao Pan; Hongliang Duan; Jianting Chen; Zhihong Zhu; Jingxin Fan; Pingfei Li; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2018-08-19       Impact factor: 6.598

7.  Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.

Authors:  Wen Lin; Yinke Li; Qiongzhi Shi; Xiangru Liao; Yuan Zeng; Wei Tian; Xiangyang Xie; Hui Liu
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

8.  Osmotic drug delivery system as a part of modified release dosage form.

Authors:  Rajesh A Keraliya; Chirag Patel; Pranav Patel; Vipul Keraliya; Tejal G Soni; Rajnikant C Patel; M M Patel
Journal:  ISRN Pharm       Date:  2012-07-17

9.  Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.

Authors:  Saeed Shojaee; Ali Nokhodchi; Mohammed Maniruzzaman
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 5.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.